Table 1.

Baseline Characteristics of the 132 Study Patients.^*

Characteristic	Value
Sex — no. (%)
Female	51 (39)
Male	81 (61)
Race or ethnic group — no. (%)†
White	130 (98)
Hispanic	2 (2)
Age
Median — yr	51.5
<65 yr — no. (%)	107 (81)
≥65 yr — no. (%)	25 (19)
No. of prior therapies — no. (%)
1	67 (51)
2	36 (27)
≥3	29 (22)
Previous interleukin-2 — no. (%)
No	81 (61)
Yes	51 (39)
Previous ipilimumab — no. (%)
Yes	7 (5)
No	125 (95)
ECOG status score — no. (%)
0	61 (46)
1	71 (54)
Metastatic stage at diagnosis — no. (%)
M1a	33 (25)
M1b	18 (14)
M1c	81 (61)
Serum LDH — no. (%)
Normal	67 (51)
Elevated	65 (49)

^*ECOG denotes Eastern Cooperative Oncology Group, and LDH lactate dehydrogenase.

^†Race or ethnic group was determined by the research staff.